Biocatalytic conversion of avermectin to 4''-oxo-avermectin: improvement of cytochrome p450 monooxygenase specificity by directed evolution.

MLA

Trefzer, Axel, et al. “Biocatalytic Conversion of Avermectin to 4’’-Oxo-Avermectin: Improvement of Cytochrome P450 Monooxygenase Specificity by Directed Evolution.” Applied and Environmental Microbiology, vol. 73, no. 13, July 2007, pp. 4317–25. EBSCOhost, https://doi.org/10.1128/AEM.02676-06.

APA

Trefzer, A., Jungmann, V., Molnár, I., Botejue, A., Buckel, D., Frey, G., Hill, D. S., Jörg, M., Ligon, J. M., Mason, D., Moore, D., Pachlatko, J. P., Richardson, T. H., Spangenberg, P., Wall, M. A., Zirkle, R., & Stege, J. T. (2007). Biocatalytic conversion of avermectin to 4’’-oxo-avermectin: improvement of cytochrome p450 monooxygenase specificity by directed evolution. Applied and Environmental Microbiology, 73(13), 4317–4325. https://doi.org/10.1128/AEM.02676-06

Chicago

Trefzer, Axel, Volker Jungmann, István Molnár, Ajit Botejue, Dagmar Buckel, Gerhard Frey, D Steven Hill, et al. 2007. “Biocatalytic Conversion of Avermectin to 4’’-Oxo-Avermectin: Improvement of Cytochrome P450 Monooxygenase Specificity by Directed Evolution.” Applied and Environmental Microbiology 73 (13): 4317–25. doi:10.1128/AEM.02676-06.